2025年3月7日， Clover Health（CLOV）披露2笔公司内部人交易情况。高管Priest Brady Patrick于2025年3月6日卖出7.50万股。 2025年3月7日 高管 Soares Karen 2025年3月6日 卖出 5.25万 3.80 19.95万 2025年3月7日 高管 Priest Brady Patrick 2025年3月6日 卖出 7.50万 3.68 ...

新泽西州泽西市——Clover Health Investments, Corp.（NASDAQ:CLOV）家庭护理CEO Brady Patrick Priest近期出售了75,000股公司A类普通股。交易发生在2025年3月6日，平均售价为每股3.68美元，总价值达27.6万美元。该公司股票在过去一年表现出显著波动性，回报率达355%，目前交易价格接近分析师4至6美元的目标区间。

根据证券交易委员会的文件显示，Clover Health Investments, Corp.（NASDAQ:CLOV）总法律顾问兼秘书Karen Soares于2025年3月6日进行了一笔重要的股票交易。Soares以每股3.80美元的价格出售了52,500股A类普通股，交易总额为199,500美元。根据 InvestingPro ...

Clover's AI capabilities drive revenue growth and efficiency, setting the stage for future profitability. Read here to know ...

Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for Clover Health Investments in a report issued on Sunday, March 2nd. Leerink Partnrs analyst W. Mayo now expects that the company ...

Highlights,Intercept Hong Kong Ltd. and other institutional investors have increased their stakes in Clover Health ...

Clover Health Investments, Corp. (NASDAQ: CLOV) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 2.55% on the day to $3.81. Clover Health Investments, Corp. operates as a ...

Clover Health Investments (NASDAQ:CLOV – Free Report) had its target price raised by Canaccord Genuity Group from $4.20 to $4.50 in a research report report published on Monday morning,Benzinga ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Clover Health Investments (CLOV – Research Report), with a ...

Q4 2024 Earnings Call Transcript February 27, 2025 Clover Health Investments, Corp. beats earnings expectations. Reported EPS is $-0.04491, expectations were $-0.07. Operator: Ladies and gentlemen, ...

Ladies and gentlemen, good afternoon and welcome to the Clover Health Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A ...

Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.12 per share ...